These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2621514)

  • 1. The argument against HIV-antibody testing in chemical dependence treatment programs.
    Sorrell SJ; Springer ER
    J Psychoactive Drugs; 1989; 21(4):419-21. PubMed ID: 2621514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The argument for HIV-antibody testing in chemical dependence treatment programs.
    Howell EF; Niven RG
    J Psychoactive Drugs; 1989; 21(4):415-7. PubMed ID: 2621513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for human immunodeficiency virus in chemical dependence treatment programs.
    Mersky SA
    J Psychoactive Drugs; 1989; 21(4):407-13. PubMed ID: 2621512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.
    Genung V
    Crit Care Nurs Clin North Am; 2012 Mar; 24(1):117-30. PubMed ID: 22405717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV infection in intravenous drug dependent patients--Vienna 1988 results].
    Loimer N; Presslich O; Hollerer E; Pfersmann V; Pakesch G; Pfersmann D
    Wien Med Wochenschr; 1989 Jul; 139(14):334-6. PubMed ID: 2788964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A high fraction of drug-dependent patients among anonymously detected HIV-infected patients in Stuttgart].
    Marquart KH
    Offentl Gesundheitswes; 1989 Mar; 51(3):115-7. PubMed ID: 2524695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for wider use of testing for HIV infection.
    Rhame FS; Maki DG
    N Engl J Med; 1989 May; 320(19):1248-54. PubMed ID: 2710203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of HIV infection among drug addicts].
    Stapiński A; Mazurkiewicz W; Ochelska B; Selibórska Z; Głuska T
    Przegl Dermatol; 1989; 76(4):326-33. PubMed ID: 2631140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment for human immunodeficiency virus among pregnant Hispanic adolescents.
    Berger DK; Rivera M; Perez G; Fierman A
    Adolescence; 1993; 28(111):597-607. PubMed ID: 8237546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS prevention and chemical dependence treatment needs of women and their children.
    Karan LD
    J Psychoactive Drugs; 1989; 21(4):395-9. PubMed ID: 2621510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care for AIDS and chemical dependence.
    Karan LD
    West J Med; 1990 May; 152(5):538-42. PubMed ID: 2190422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping with AIDS: strategies for patients and staff in drug abuse treatment programs.
    Sorensen JL; Costantini MF; London JA
    J Psychoactive Drugs; 1989; 21(4):435-40. PubMed ID: 2621517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid HIV testing and counseling for voluntary testing centers in Africa.
    McKenna SL; Muyinda GK; Roth D; Mwali M; Ng'andu N; Myrick A; Luo C; Priddy FH; Hall VM; von Lieven AA; Sabatino JR; Mark K; Allen SA
    AIDS; 1997 Sep; 11 Suppl 1():S103-10. PubMed ID: 9376093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
    Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
    N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS prevention is thicker than blood. Zimbabwe.
    Steinberg J
    Links; 1992; 9(2):3. PubMed ID: 12159269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting information and education, and behaviour change.
    Ross MW
    AIDS Care; 1991; 3(4):419-21. PubMed ID: 1786277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year.
    Hart GJ; Carvell AL; Woodward N; Johnson AM; Williams P; Parry JV
    AIDS; 1989 May; 3(5):261-5. PubMed ID: 2504229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.